DTx WEST 2020
Event Information

DTx WEST 2020

February 17–19 | San Mateo, CA

Defining How To Achieve Commercial And Patient Success With Digital Therapeutics

Registration Agenda

2019 Partners

Founding Partners
Sanofi

Sanofi Digital Medicine, under the Chief Medical Office, improves patient outcomes through the development of innovative technology-driven solutions that when combined with drugs, improve treatment efficacy, safety, adherence and overall experience.

Dthera Sciences

Dthera Sciences is working to create a truly innovative digital therapeutic to meaningfully improve the quality of life and reduce loneliness in those with Alzheimer’s Disease, Dementia, and Senior Isolation.

Cognoa

Cognoa’s digital diagnostics and personalized therapeutics improve the timeliness, scale, and effectiveness of behavioral healthcare. Their first clinically-validated mobile application identified autism on average 13 months earlier than the national average and as early as 18 months – when early intervention has the greatest potential for improved life-long outcomes.

Supporters
Akili

Akili is a prescription digital medicine company combining scientific and clinical rigor with the ingenuity of the tech industry to reinvent medicine. Pioneering the development of digital treatments with direct therapeutic activity and delivered through captivating video game experiences, Akili is advancing a broad pipeline of programs to treat cognitive deficiency.

Canary health

Canary Health is the leading provider of digital health self-management programs that prevent the progression of chronic diseases including arthritis, depression, diabetes, and heart disease. Our mission is to empower people with the tools, coaching and community support to self-manage their health, enhancing their quality of life, improving health outcomes, and lowering the cost of care.

Click Therapeutics

Click Therapeutics, Inc. develops and commercializes software as prescription medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Following a groundbreaking clinical trial, Click’s industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click’s lead prescription program is entering into a multi-center, randomized, controlled, parallel-group, phase III FDA registration trial for the treatment of Major Depressive Disorder in adults.

Jazz Venture Partners

JAZZ Venture Partners invests in companies that extend the boundaries of human performance — improving how we live, learn, work, play, and experience the world.

We seek breakthroughs at the intersection of digital technology and neuroscience that are influencing the human experience, such as augmented reality, artificial intelligence, immersive gaming, and closed-loop human-computer systems.

Our portfolio companies are unlocking human potential in health, mind-body wellness, accelerated learning and training, sports, entertainment, and the enterprise.

Knowledge Partners
The Learning Corp

The Learning Corp designs mobile applications for continuous and customizable therapy for people with speech, language, cognition, memory, and learning disorders.

Tali

TALI Health Pty Ltd is based in Melbourne, Australia and is made up of a team of neuroscientists, software engineers, game developers and all-round talented individuals. Our vision is to be a leader in the assessment and treatment of childhood attention difficulties. We aim to assist children in reaching their full potential by providing engaging training software clinically proven to improve core cognitive performance.

Simon-Kucher

TopLine Power® is what Simon-Kucher is all about. We help clients grow revenue through optimization of strategy, pricing, marketing, and sales across industries.

We are a thought leader in these topics at the intersection of digitalization and life sciences, positioning our clients to thrive in the healthcare industry of the future.

EnvoyHealth

EnvoyHealth is the leader in the implementation and delivery of comprehensive commercialization and market access strategies for digital therapeutic brands. Our solutions focus on understanding the needs of your customers and delivering tailored solutions that promote patient engagement, advance payor coverage, and provide you with the data and insights you need to drive your business. In a challenging and complex healthcare environment, you need an experienced team to support your go to market strategy. EnvoyHealth’s leadership team has extensive experience bringing new and innovative products to market. We are here to listen, build, and deliver. Contact us today at Dtx@envoyhealth.is

Match Point

Match Point, celebrating our 10th Anniversary, provides a unique blend of value-added investment banking, strategic, and operating services to healthcareand technology firms. Founded in 2009, with offices in New York City, San Francisco, and Washington D.C., our team of experienced entrepreneurs, bankers, and operators collaborates to develop and execute creative, innovative, and often out-of-the-box solutions to help our clients achieve superior value.

ZS

ZS is the world’s largest firm focused exclusively on helping companies improve overall performance and grow revenue and market share through end-to-end sales and marketing solutions—from customer insights and strategy, to analytics, operations and technology. More than 6,000 ZS professionals in 23 offices worldwide draw on deep industry and domain expertise to deliver impact for clients across multiple industries. To learn more, visit www.zs.com or follow us on Twitter and LinkedIn.

BrightInsight

BrightInsight, a Flex Company, provides the leading global regulated digital health platform for biopharma and medtech. Our medical-grade Internet of Things (IoT) platform is built under a Quality Management System to support and optimize regulated drugs, devices and software through integrated data and actionable insights to enable customers to drive increased patient adherence and engagement. The BrightInsight™ Platform uses software and services to capture, transmit and analyze data from CE-marked and FDA-regulated medical devices, combination products, apps and Software as a Medical Device, in compliance with security, privacy and regulatory requirements.

Summit Partners
IQVIA

IQVIA (NYSE:IQV) is a leading global provider of information, innovative technology solutions and contract research services focused on helping healthcare clients find better solutions for patients. Formed through the merger of IMS Health and Quintiles, IQVIA applies Human Data Science — leveraging the analytic rigor and clarity of data science to the ever-expanding scope of human science — to enable companies to reimagine and develop new approaches to clinical development and commercialization, speed innovation and accelerate improvements in healthcare outcomes.

Key Numbers of DTx
200+
Attendees

Be part of the 200+ person audience of senior executives who are driving forward the development of Digital Therapeutics

50+
Expert speakers

Learn from the industry-defining speaker faculty, comprised of the pioneers of the industry and the most exciting new-comers

10
Hours of networking

The audience is the who’s who of the industry. From every leading Digital Therapeutic company to Pharma, HCP’s and Investors

“I found this conference eye-opening and had many interesting conversations. I am blown away by the Digital Therapeutics community and its commitment to value-based care”

Laura Kleiman - Founder and Executive Director, Cures Within Reach for Cancer

“The conference was tangible, specific and open. I have never been to a conference of this size with such richness of discussion”

Frederico Calado - Health Data Policy Director, Novartis

“DTx is the must attend event in our industry”

Eddie Martucci - CEO, Akili Interactive

“Thanks for catalyzing the industry forward in this emerging field. Looking forward to the next one”

Cris de Luca - Global Director, Innovation, Johnson and Johnson Technology

“The DTx Series is a fantastic set of meetings. The quality of the investors, entrepreneurs and companies never fails to impress me, and I always leave having learned a lot”

John Spinale - General Partner, JAZZ Venture Partners

“DTx is an inclusive event, where the participants truly believe that the rising tide will raise all boats”

Mette Dyhrberg - Founder and CEO, MyMee Inc

“DTx is a great event! there is a great mix of digital innovators and large companies which deliver high-quality content. I learn a lot and it’s great to see this community come together and have authentic interactions”

Adam Kaufman - CEO, Canary Health

2019 Speakers

MATT COOK
MATT COOK
Vice President, Commercial Strategy & Business Development
Business Development, Omada Health
MATT COOK
Vice President, Commercial Strategy & Business Development
Business Development, Omada Health
ANAND IYER
ANAND IYER
Chief Strategy Officer
WellDoc
ANAND IYER
Chief Strategy Officer
WellDoc
STEPHANIE TILENIUS
STEPHANIE TILENIUS
CEO
Vida Health
STEPHANIE TILENIUS
CEO
Vida Health
JAVIER GARCIA PALACIOS
JAVIER GARCIA PALACIOS
Director, Digital Health Ventures
Bayer, #G4A
JAVIER GARCIA PALACIOS
Director, Digital Health Ventures
Bayer, #G4A
METTE DYHRBERG
METTE DYHRBERG
CEO
Mymee
METTE DYHRBERG
CEO
Mymee
EDDIE MARTUCCI
EDDIE MARTUCCI
CEO
Akili Interactive Labs
EDDIE MARTUCCI
CEO
Akili Interactive Labs
BRIAN HARRIS
BRIAN HARRIS
Co-Founder & CEO
MedRhythms Inc.
BRIAN HARRIS
Co-Founder & CEO
MedRhythms Inc.
ALEX WALDRON
ALEX WALDRON
Chief Commercial Officer
Pear Therapeutics
ALEX WALDRON
Chief Commercial Officer
Pear Therapeutics
ANDRÉ HEEG
ANDRÉ HEEG
Head of Digital
Sandoz
ANDRÉ HEEG
Head of Digital
Sandoz
CHRIS WASDEN
CHRIS WASDEN
Head of Pharma
Happify
CHRIS WASDEN
Head of Pharma
Happify
MEGAN JONES-BELL
MEGAN JONES-BELL
Chief Scientific Officer
Headspace
MEGAN JONES-BELL
Chief Scientific Officer
Headspace
JOEL SANGERMAN
JOEL SANGERMAN
Chief Commercial Officer
Click Therapeutics
JOEL SANGERMAN
Chief Commercial Officer
Click Therapeutics
ROSEMARY KU
ROSEMARY KU
Founder
Executive Director, Cure Chronic Disease
ROSEMARY KU
Founder
Executive Director, Cure Chronic Disease
DAVID STEVENSON
DAVID STEVENSON
Managing Director
Merck Global Health Innovation Fund
DAVID STEVENSON
Managing Director
Merck Global Health Innovation Fund
EDWARD COX
EDWARD COX
CEO
Dthera Sciences
EDWARD COX
CEO
Dthera Sciences
JOE SLAVINSKY
JOE SLAVINSKY
VP
Propeller Health
JOE SLAVINSKY
VP
Propeller Health
BRENT VAUGHAN
BRENT VAUGHAN
CEO & Co-Founder
Cognoa
BRENT VAUGHAN
CEO & Co-Founder
Cognoa
DAVID AMOR
DAVID AMOR
VP
Quality & Regulatory Affairs, Pear Therapeutics
DAVID AMOR
VP
Quality & Regulatory Affairs, Pear Therapeutics
RUCHITA SINHA
RUCHITA SINHA
Senior Director, Investment
Sanofi Ventures
RUCHITA SINHA
Senior Director, Investment
Sanofi Ventures
GIANGIACOMO ROCCO DI TORREPADULA
GIANGIACOMO ROCCO DI TORREPADULA
CEO & Co-Founder
AMICOMED
GIANGIACOMO ROCCO DI TORREPADULA
CEO & Co-Founder
AMICOMED
SHARIEF TARAMAN
SHARIEF TARAMAN
Chief Medical Officer
Cognoa
SHARIEF TARAMAN
Chief Medical Officer
Cognoa
TAYLOR MAHAN-RUDOLPH
TAYLOR MAHAN-RUDOLPH
Director, Quality & Regulatory
Propeller Health
TAYLOR MAHAN-RUDOLPH
Director, Quality & Regulatory
Propeller Health
DAVID KIM
DAVID KIM
CEO
DigiTx Partners
DAVID KIM
CEO
DigiTx Partners
SHAHRAM SEYEDIN-NOOR
SHAHRAM SEYEDIN-NOOR
Founder & General Partner
Civilization Ventures
SHAHRAM SEYEDIN-NOOR
Founder & General Partner
Civilization Ventures
MATTHIAS ZENKER
MATTHIAS ZENKER
Partner
Gaia AG
MATTHIAS ZENKER
Partner
Gaia AG
CHRIS RAINE
CHRIS RAINE
Founder & Chief Executive Officer
Hello Sunday Morning
CHRIS RAINE
Founder & Chief Executive Officer
Hello Sunday Morning
AUSTIN SPEIER
AUSTIN SPEIER
Chief Strategy Officer
Click Therapeutics
AUSTIN SPEIER
Chief Strategy Officer
Click Therapeutics
SASHA SAID
SASHA SAID
Vice President
Leerink Transformation Partners
SASHA SAID
Vice President
Leerink Transformation Partners
PETER HAMES
PETER HAMES
Co-Founder & Chief Executive Officer
Big Health
PETER HAMES
Co-Founder & Chief Executive Officer
Big Health
DEBRA REISENTHEL
DEBRA REISENTHEL
Founding CEO
Palo Alto Health Sciences
DEBRA REISENTHEL
Founding CEO
Palo Alto Health Sciences
OWEN MCCARTHY
OWEN MCCARTHY
Co-Founder & President
MedRhythms Inc.
OWEN MCCARTHY
Co-Founder & President
MedRhythms Inc.
STACEY CURTISS
STACEY CURTISS
Senior Director & Leader, Medical Science Liaisons
Akili Interactive
STACEY CURTISS
Senior Director & Leader, Medical Science Liaisons
Akili Interactive
AUSTIN SPEIER
AUSTIN SPEIER
Chief Strategy Officer
Click Therapeutics
AUSTIN SPEIER
Chief Strategy Officer
Click Therapeutics
ADAM KAUFMAN
ADAM KAUFMAN
President & Chief Executive Officer
Canary Health
ADAM KAUFMAN
President & Chief Executive Officer
Canary Health
JEFFREY ABRAHAM
JEFFREY ABRAHAM
Vice President
Market Access & Trade, Akili Interactive
JEFFREY ABRAHAM
Vice President
Market Access & Trade, Akili Interactive
FLORIAN SCHUBERT
FLORIAN SCHUBERT
Director
Digital Strategy, Sandoz
FLORIAN SCHUBERT
Director
Digital Strategy, Sandoz
JAMES MUSICK
JAMES MUSICK
Vice President & Head
Neurology Patient Technology, UCB
JAMES MUSICK
Vice President & Head
Neurology Patient Technology, UCB
VISHAL DUBEY
VISHAL DUBEY
Chief Product Officer
AMICOMED
VISHAL DUBEY
Chief Product Officer
AMICOMED
VEERA ANANTHA
VEERA ANANTHA
Founder, CTO & President
The Learning Corp
VEERA ANANTHA
Founder, CTO & President
The Learning Corp
MATTHEW TUCKER
MATTHEW TUCKER
Executive Director, Marketing Strategy
Highmark Health
MATTHEW TUCKER
Executive Director, Marketing Strategy
Highmark Health
DAVID LEE
DAVID LEE
Partner
Simon Kucher & Partners
DAVID LEE
Partner
Simon Kucher & Partners
KIM CORNISH
KIM CORNISH
Director, Monash Institute of Cognitive & Clinical Neurosciences (MICCN)
Co-Inventor of Tali Train Monash University
KIM CORNISH
Director, Monash Institute of Cognitive & Clinical Neurosciences (MICCN)
Co-Inventor of Tali Train Monash University
MEGAN CODER
MEGAN CODER
Executive Director
Digital Therapeutics Alliance
MEGAN CODER
Executive Director
Digital Therapeutics Alliance
ABHISHEK SHAH
ABHISHEK SHAH
CEO
Wellthy Therapeutics
ABHISHEK SHAH
CEO
Wellthy Therapeutics
CHIN-WEI SOO
CHIN-WEI SOO
Global Regulatory Head, Combination Products and Devices
Genentech
CHIN-WEI SOO
Global Regulatory Head, Combination Products and Devices
Genentech
DEREK COTHRAN
DEREK COTHRAN
Senior Vice President, Client Strategy and Development
EnvoyHealth
DEREK COTHRAN
Senior Vice President, Client Strategy and Development
EnvoyHealth
IANA DIMKOVA
IANA DIMKOVA
Director
Healthcare Investing, GE Ventures
IANA DIMKOVA
Director
Healthcare Investing, GE Ventures
JEFF GOMBALA
JEFF GOMBALA
Associate Principal
ZS Associates
JEFF GOMBALA
Associate Principal
ZS Associates
MAURICE SOLOMON
MAURICE SOLOMON
Associate Principal
ZS Associates
MAURICE SOLOMON
Associate Principal
ZS Associates
BRAD BURKETT
BRAD BURKETT
Founder & Managing Partner
Match Point Partners LLC
BRAD BURKETT
Founder & Managing Partner
Match Point Partners LLC
KAL PATEL, MD
KAL PATEL, MD
President
BrightInsight, a Flex Company
KAL PATEL, MD
President
BrightInsight, a Flex Company
ANTOUN NABHAN
ANTOUN NABHAN
Vice President, Corporate Development
Pear Therapeutics
ANTOUN NABHAN
Vice President, Corporate Development
Pear Therapeutics
KIRAN HEGDE
KIRAN HEGDE
Head, BD&L, Search and Evaluation
Sandoz
KIRAN HEGDE
Head, BD&L, Search and Evaluation
Sandoz
DAVID KEENE
DAVID KEENE
Chief Technology Officer
Dthera Sciences
DAVID KEENE
Chief Technology Officer
Dthera Sciences
PIERRE LEURENT
PIERRE LEURENT
Chief Executive Officer
Voluntis
PIERRE LEURENT
Chief Executive Officer
Voluntis
MARTIN CULJAT
MARTIN CULJAT
Vice President, Scientific & Regulatory Affairs
Dthera Sciences
MARTIN CULJAT
Vice President, Scientific & Regulatory Affairs
Dthera Sciences
BRYCE WILLIAMS
BRYCE WILLIAMS
Lifestyle Medicine
Blue Shield of California
BRYCE WILLIAMS
Lifestyle Medicine
Blue Shield of California
MICHAEL FAHMY
MICHAEL FAHMY
Senior Director, Global Regulatory Affairs
Otsuka
MICHAEL FAHMY
Senior Director, Global Regulatory Affairs
Otsuka

Below are the 2019 workshops & agenda.

Details for 2020 will be shared shortly.

Workshops

  • Digital Therapeutics 101
  • Pharma and Digital Therapeutics
Digital Therapeutics 101
Digital Therapeutics 101 WORKSHOP LEADERS

Jeffrey Abraham, Vice President, Market Access & Trade, Akili Interactive
Stacey Curtiss, Senior Director & Leader, Medical Science Liaisons, Akili Interactive

9:00
Presentation: What is the Current State of Play with the Digital Therapeutics Industry?
9:30
Breakout Discussions

Splitting into smaller working groups, each group will discuss their current views on digital therapeutics as a concept and their views on the different facets of the industry.

  • Are we comfortable with the definition of a digital therapeutic?
  • Generally speaking, how do payers, pharma and regulatory authorities view digital therapeutics?
  • What lessons can we draw on from working with other related industries?
  • What are our thoughts on the other similar digital medicine approaches out there?
  • What remaining questions do we have about digital therapeutics?
10:30
Refreshment Break
11:00
Feedback Discussions

Representative(s) from each group share the main points from their discussion to the whole group. Additional questions form moderators and other group members will be raised during this collaborative discussion.

12:00
End of Workshop

Leave this workshop with:

  • Fundamental questions answered around what a digital therapeutic is being defined as compared to other digital interventions
  • A deeper understanding of the current payer and provider perspectives on digital therapeutics and how these are looking to be advanced
  • Up-to-date information on the different ways pharma are involved in the industry
  • A fundamental understanding of the current regulatory pathways in and around the industry
  • A stronger appreciation of the crucial questions facing the industry that will be tackled during the rest of the Summit
Pharma and Digital Therapeutics
Pharma and Digital Therapeutics WORKSHOP LEADERS

James Musick, Vice President & Head, Neurology Patient Technology, UCB
Sasha Said, Vice President, Leerink Transformation Partners
Florian Schubert, Director, Digital Strategy, Sandoz
Chris Wasden, Head of Pharma, Happify

1:00
Presentation: What are the Current Sentiments from Pharma Towards Digital Therapeutics?
1:30
Breakout Discussions

Splitting into smaller working groups, each group will discuss their own thoughts and pharma’s current
thoughts on digital therapeutics and what it is going to take to make DTx-pharma partnerships successful.

  • What is our understanding of the expectations from different types of DTx-pharma partnerships?
  • How do digital therapeutics fit into the short-term and long-term goals of pharma?
  • Are pharma more excited about the therapeutic entity or the data produced by digital therapeutics?
  • How should pharma adapt their mindsets to maximize the impact of their work with digital therapeutics?
  • How do digital therapeutic companies needs to adapt to maximize the impact of their work with pharma?
2:30
Refreshments
3:00
Feedback Discussions

Representative(s) from each group share the main points from their discussion to the whole group. Additional questions form moderators and other group members will be raised during this collaborative discussion.

4:00
End of Workshop

Leave this workshop with:

  • Deeper understanding of the current ways pharma are partnering with digital therapeutics companies
  • Full clarification on the expectations pharma have when in a working partnership with digital therapeutic companies compared to purely investing in them
  • Discussion points around how pharma currently view digital therapeutics in their short-term and long-term strategies
  • Understanding around how different departments in pharma will impact their work in this industry and where a change of mindset is needed
  • An understanding of why some pharma are still reluctant to partner with digital therapeutic companies

Below is the 2019 agenda. Details for 2020 will be shared shortly.

2019 Agenda

  • Day One
  • Day Two
Day One
8:00
Day One - Registration, Breakfast & Networking
9:00
Chair’s Opening Remarks & Setting the Scene

Joel Sangerman, Chief Commercial Officer, Click Therapeutics

9:10
Presentation: The Economic Value Proposition of Digital Therapeutics

Anand Iyer, Chief Strategy Officer, WellDoc

9:30
Presentation: From Theory to Impact: Lessons Learned from Scaling Digital Medicine in the UK & US

Peter Hames, Co-Founder & Chief Executive Officer, Big Health

9:50
Panel: What is it Going take for Digital Therapeutics to Succeed Commercially?

Anand Iyer, Chief Strategy Officer, WellDoc
Eddie Martucci, Chief Executive Officer, Akili Interactive
Brent Vaughan, Chief Executive Officer, Cognoa
Alex Waldron, Chief Commercial Officer, Pear Therapeutics
David Lee, Partner, Simon Kucher & Partners

10:30
Morning Refreshments & Networking
11:00
Under the Microscope: Crucial DTx Questions

These small group discussions provide a unique opportunity to get into the key detail of the challenges and opportunities of crucial questions facing digital therapeutics. Each session has been curated to bring expert moderators together in order for attendees to find questions in a peer-to-peer format.

Attendees will be able to attend 3 roundtables, which are 30 minutes each. Get ready for plenty of takeaways in this 90 minute session!

Roundtable 1: Transitioning and Evolving Towards Digital Therapeutics

Ed Cox, Chief Executive Officer, Dthera Sciences
Martin Culjat, Vice President, Scientific & Regulatory Affairs, Dthera Sciences
David Keene, Chief Technology Officer, Dthera Sciences

Roundtable 2: Building Go-to-Market and Partnership Strategies for US and European Markets

Giangiacomo Rocco di Torrepadula, Chief Executive Officer & Co-Founder, AMICOMED
Vishal Dubey, Chief Product Officer, AMICOMED

Roundtable 3: Putting the Patient at the Center: Convergence of Patient Services and Digital Therapeutics

Jeff Gombala, Associate Principal, ZS Associates
Maurice Solomon, Associate Principal, ZS Associates

Roundtable 4: Working with a Payer – From Medical Policy to Commercialization

Debra Reisenthel, Founding CEO, Palo Alto Health Sciences
Matthew Tucker, Executive Director, Marketing Strategy, Highmark Health

Roundtable 5: Digital Therapeutics and Pharma Partnership Models

Antoun Nabhan, Vice President, Corporate Development, Pear Therapeutics
Kiran Hegde, Head, BD&L, Search and Evaluation, Sandoz
Joe Slavinsky, VP, Business Development, Propeller Health

Roundtable 6: What do Digital Therapeutic Companies need to Display to Investors to Secure Funding?

Sasha Said, Vice President, Leerink Transformation Partners

12:30
Lunch & Networking
1:45
Presentation: The Evolution of Digital Therapeutics Commercialization and Scalability

Matt Cook, Vice President, Commercial Strategy & Business Development, Omada Health

2:10
Presentation: Breaking Down Silos: Why Digital Health Solutions Need the Ecosystem to Succeed

Kal Patel, MD, President, BrightInsight, a Flex Company

2:35
Presentation: Digital Therapeutics Commercialization: Market Access Support Drives Digital Therapeutic Success

Derek Cothran, Senior Vice President, Client Strategy and Development, EnvoyHealth

3:00
Panel: Why are Companies Now Starting to Pivot Toward Digital Therapeutics?

Moderator: Adam Kaufman, President & Chief Executive Officer, Canary Health
Megan Jones-Bell, Chief Scientific Officer, Headspace
Ed Cox, Chief Executive Officer, Dthera Sciences
David Stevenson, Managing Director, Merck Global Health Innovation Fund

3:40
Afternoon Refreshments & Networking
4:15
Presentation: Scalable Digital Tools for Detecting and Training Clinical Inattention Early in Life

Kim Cornish, Director, Monash Institute of Cognitive & Clinical Neurosciences (MICCN), Monash University | Co-Inventor of Tali Train, Tali Health

4:30
Panel: The In’s and Out’s of the Regulatory Approval Pathways

Moderator: David Amor, Vice President, Quality & Regulatory Affairs, Pear Therapeutics
Taylor Mahan-Rudolph, Director, Quality & Regulatory, Propeller Health
Austin Speier, Chief Strategy Officer, Click Therapeutics
Chin-Wei Soo, Global Regulatory Head, Combination Products and Devices, Genentech, a Member of the Roche Group
Michael Fahmy, Senior Director, Global Regulatory Affairs, Otsuka

5:10
Panel: How do Digital Therapeutics need to Adapt to The Healthcare System to be Routinely Prescribed?

Moderator: Sharief Taraman, Chief Medical Officer, Cognoa | Chief of Neurology, Children’s Hospital of Orange County
Rosemary Ku, Urgent Care Physician, Kaiser Permanente | Founder, Executive Director, Cure Chronic Disease
Stephanie Tilenius, Chief Executive Officer & Founder, Vida Health
Veera Anantha, Founder, CTO & President, The Learning Corp

5:50
Drinks Reception
Day Two
8: 00
Day Two - Breakfast & Networking
9:00
Chair’s Opening Remarks

Mette Dyhrberg, Chief Executive Officer, Mymee

9:05
Presentation: Digital Therapeutics: Pursuing the Next Phase of Industry Evolution

Megan Coder, Executive Director, Digital Therapeutics Alliance

9:20
Presentation: Financing and Growing Digital Therapeutic Companies

Brad Burkett, Founder & Managing Partner, Match Point Partners LLC

9:40
Presentation: Commercializing and Scaling Prescription Digital Therapeutics

André Heeg, Head of Digital, Sandoz

10:05
Panel: Pharma and Digital Therapeutics: A Match Made in Heaven?

Moderator: Pierre Leurent, Chief Executive Officer, Voluntis
André Heeg, Head of Digital, Sandoz
Ruchita Sinha, Senior Director, Investment, Sanofi Ventures
Javier Garcia Palacios, Director, Digital Health Ventures, Bayer, #G4A

10:45
Morning Refreshments & Networking
11:15
Presentation: European Perspective on Digital Therapeutics – Fitting into Universal Healthcare Systems and Beyond

Matthias Zenker, Partner, GAIA AG

11:35
Presentation: Evidence-based Digital Interventions Using Music and Neuroscience

Brian Harris, Co-Founder & CEO, MedRhythms Inc.

11:55
Presentation: Pivoting from Digital Health to Digital Therapeutics in Alcohol Behavioural Change

Chris Raine, Founder & Chief Executive Officer, Hello Sunday Morning

12:15
Presentation: How to Build and Scale Digital Therapeutics in Emerging Markets?

Abhishek Shah, Chief Executive Officer, Wellthy Therapeutics

12:35
Presentation – Digital Therapeutics Payor Adoption

Bryce Williams, Vice President, Lifestyle Medicine, Blue Shield of California

12:55
Lunch & Networking
1:55
Panel: How and When Will the Digital Therapeutics Market Consolidate?

David Kim, CEO, DigiTx Partners
Owen McCarthy, Co-Founder & President, MedRhythms Inc.
Shahram Seyedin-Noor, Founder & General Partner, Civilization Ventures
Iana Dimkova, Director, Healthcare Investing, GE Ventures

2:35
Chair’s Summary

Mette Dyhrberg, Chief Executive Officer, Mymee

2:40
Close of DTx West 2019

Partner with us

SPONSORSHIP
The DTx summits are the premier events for senior executives from DTx companies, Pharma, Investors, HCPs and Payers.

DTx West 2019 is the third summit in the series, the first two were sell-outs. We are expecting 200 people at the summit in San Mateo, which is what our attendees and sponsors tell us is the optimum size

We believe that getting the right mix of sponsors is critical for a successful summit for you and our attendees. The DTx summit provides a rare opportunity to showcase your business to a world class audience.

You will be impressed with our service and truthfulness. We will be honest with you throughout the process from deciding which option is right for you to delivery on-site.

With 5 companies confirmed pre-launch, sponsor and supporter spaces are selling fast. Get in touch today to learn more to avoid missing out!

Contact Us +
Partner with us

Register for the Event

Pre-launch price expires October 4th

For pricing and booking options please click the button to go to the registration page.

Registration